X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1579) 1579
Publication (83) 83
Book Review (24) 24
Newsletter (21) 21
Magazine Article (5) 5
Book Chapter (4) 4
Transcript (4) 4
Conference Proceeding (1) 1
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1352) 1352
dapsone - adverse effects (770) 770
male (751) 751
female (725) 725
dapsone (658) 658
adult (610) 610
dapsone - therapeutic use (593) 593
middle aged (446) 446
index medicus (375) 375
dermatology (330) 330
dapsone - administration & dosage (288) 288
aged (255) 255
adolescent (229) 229
drug therapy, combination (218) 218
leprosy - drug therapy (212) 212
treatment outcome (176) 176
child (152) 152
pharmacology & pharmacy (134) 134
anti-infective agents - adverse effects (122) 122
methemoglobinemia - chemically induced (122) 122
medicine, general & internal (121) 121
animals (117) 117
drug therapy (113) 113
leprostatic agents - adverse effects (111) 111
infectious diseases (110) 110
anti-infective agents - therapeutic use (108) 108
leprosy (106) 106
care and treatment (105) 105
therapy (98) 98
retrospective studies (97) 97
leprostatic agents - therapeutic use (87) 87
tropical medicine (86) 86
dermatitis herpetiformis - drug therapy (85) 85
follow-up studies (80) 80
rifampin - therapeutic use (80) 80
drug combinations (79) 79
research (77) 77
aged, 80 and over (75) 75
young adult (74) 74
child, preschool (73) 73
time factors (71) 71
pneumonia, pneumocystis - prevention & control (70) 70
immunosuppressive agents - therapeutic use (69) 69
health aspects (68) 68
immunology (65) 65
pyrimethamine - adverse effects (65) 65
risk factors (65) 65
methemoglobinemia (64) 64
clofazimine - therapeutic use (63) 63
diagnosis (63) 63
disease (63) 63
malaria (62) 62
complications and side effects (61) 61
drug hypersensitivity - etiology (61) 61
acne (60) 60
anemia, hemolytic - chemically induced (60) 60
antimalarials - adverse effects (60) 60
recurrence (60) 60
dosage and administration (59) 59
infant (59) 59
pregnancy (59) 59
anti-infective agents - administration & dosage (58) 58
drugs (58) 58
pneumonia, pneumocystis - drug therapy (58) 58
syndrome (57) 57
medicine & public health (56) 56
pneumonia (56) 56
skin (56) 56
antimalarials - therapeutic use (55) 55
diagnosis, differential (55) 55
agranulocytosis - chemically induced (54) 54
biopsy (54) 54
pathology (54) 54
dose-response relationship, drug (53) 53
rifampin - administration & dosage (53) 53
trimethoprim-sulfamethoxazole (53) 53
aids (52) 52
rifampin - adverse effects (52) 52
dapsone - pharmacology (51) 51
patients (51) 51
skin - pathology (51) 51
prevention (50) 50
skin diseases (50) 50
administration, oral (49) 49
children (49) 49
corticosteroids (49) 49
double-blind (49) 49
leprostatic agents - administration & dosage (48) 48
clofazimine - adverse effects (47) 47
toxicity (47) 47
drug administration schedule (46) 46
drug eruptions - etiology (46) 46
anti-inflammatory agents - therapeutic use (45) 45
dapsone - metabolism (45) 45
dermatology & venereal diseases (45) 45
prophylaxis (45) 45
acne vulgaris - drug therapy (44) 44
efficacy (44) 44
hematology (44) 44
pediatrics (43) 43
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1499) 1499
French (49) 49
German (27) 27
Spanish (12) 12
Portuguese (5) 5
Danish (4) 4
Dutch (3) 3
Japanese (3) 3
Polish (3) 3
Chinese (2) 2
Hebrew (2) 2
Italian (2) 2
Korean (2) 2
Croatian (1) 1
Hungarian (1) 1
Norwegian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 06/2018, Volume 13, Issue 6, p. e0198184
Background Many patients with immune thrombocytopenia (ITP) may require special attention and long-term treatment. Little is known on the efficacy and... 
AUTOIMMUNE THROMBOCYTOPENIA | TREATMENT OPTIONS | ADULT PATIENTS | INTRAVENOUS GAMMA-GLOBULIN | MANAGEMENT | ANTI-D | MEDICAL THERAPY | SAFETY | PURPURA | ROMIPLOSTIM | MULTIDISCIPLINARY SCIENCES | Prednisolone - adverse effects | Azathioprine - therapeutic use | Pyrazoles - therapeutic use | Benzoates - therapeutic use | Recombinant Fusion Proteins - adverse effects | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Immunoglobulins, Intravenous - adverse effects | Child, Preschool | Dexamethasone - adverse effects | Male | Dapsone - therapeutic use | Purpura, Thrombocytopenic, Idiopathic - drug therapy | Receptors, Fc - therapeutic use | Splenectomy | Young Adult | Aged, 80 and over | Child | Rituximab - adverse effects | Purpura, Thrombocytopenic, Idiopathic - surgery | Combined Modality Therapy | Remission Induction | Cyclosporine - therapeutic use | Dexamethasone - therapeutic use | Immunoglobulins, Intravenous - therapeutic use | Rho(D) Immune Globulin - adverse effects | Cyclosporine - adverse effects | Adolescent | Rho(D) Immune Globulin - therapeutic use | Dapsone - adverse effects | Benzoates - adverse effects | Recombinant Fusion Proteins - therapeutic use | Thrombopoietin - therapeutic use | Purpura, Thrombocytopenic, Idiopathic - therapy | Rituximab - therapeutic use | Adult | Female | Prednisolone - therapeutic use | Retrospective Studies | Drug Therapy, Combination | Drug Resistance | Pyrazoles - adverse effects | Hydrazines - therapeutic use | Treatment Outcome | Thrombopoietin - adverse effects | Immunosuppressive Agents - adverse effects | Aged | Azathioprine - adverse effects | Hydrazines - adverse effects | Thrombocytopenic purpura | Clinical trials | Treatment outcome | Care and treatment | Analysis | Drugs | Thrombocytopenia | Therapy | Immunoglobulins | Dexamethasone | Intravenous administration | Medical treatment | Medical services | Patients | Immunosuppressive agents | Bleeding | Medicine | Remission | Clinical medicine | Azathioprine | Drug dosages | Prednisolone
Journal Article
JAMA Dermatology, ISSN 2168-6068, 04/2018, Volume 154, Issue 4, pp. 441 - 446
IMPORTANCE: Dapsone-induced hypersensitivity syndrome (DHS) is a life-threatening adverse drug reaction. Based on available epidemiologic studies, HLA... 
ALLELE | RISK | LEPROSY PATIENTS | HYPERSENSITIVITY SYNDROME | HLA | DERMATOLOGY | Dapsone - adverse effects | Anti-Infective Agents - adverse effects | Humans | Drug Hypersensitivity Syndrome - genetics | Genotype | Drug Eruptions - epidemiology | Drug Eruptions - genetics | HLA-B13 Antigen - genetics | Online First | Original Investigation | Research
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2013, Volume 110, Issue 43, pp. 17486 - 17491
Individuals with glucose 6-phosphate dehydrogenase (G6PD) deficiency are at risk for the development of hemolytic anemia when given 8-aminoquinolines (8-AQs),... 
Hemolysis | Dehydrogenases | Malaria | Erythrocytes | Antimalarials | Mice | Drug design | Reticulocytes | Dosage | Blood | IMMUNOCOMPROMISED MICE | IMMUNODEFICIENT MICE | PROPHYLAXIS | TRANSMISSION | SCID MOUSE | HUMAN MALARIA | PLASMODIUM-FALCIPARUM | TAFENOQUINE | MULTIDISCIPLINARY SCIENCES | PRIMAQUINE | Dapsone - adverse effects | Humans | Transplantation, Heterologous | Dapsone - therapeutic use | Erythrocyte Transfusion - methods | Dose-Response Relationship, Drug | Mefloquine - therapeutic use | Sensitivity and Specificity | Female | Doxycycline - adverse effects | Pyrimethamine - therapeutic use | Antimalarials - adverse effects | Drug Evaluation, Preclinical - methods | Reproducibility of Results | Glucosephosphate Dehydrogenase Deficiency - blood | Pyrimethamine - adverse effects | Doxycycline - therapeutic use | Glucosephosphate Dehydrogenase Deficiency - therapy | Chloroquine - therapeutic use | Antimalarials - therapeutic use | Combined Modality Therapy | Chloroquine - adverse effects | Mice, SCID | Mefloquine - adverse effects | Animals | Primaquine - therapeutic use | Anemia, Hemolytic - diagnosis | Anemia, Hemolytic - chemically induced | Mice, Inbred NOD | Primaquine - adverse effects | Anemia, Hemolytic - blood | Aminoquinolines - therapeutic use | Erythrocyte Count | Aminoquinolines - adverse effects | Phosphates | Physiological aspects | Oxidoreductases | Anemia | Health aspects | Risk factors | Index Medicus | Biological Sciences
Journal Article
by
American Journal of Clinical Dermatology, ISSN 1175-0561, 04/2001, Volume 2, Issue 4, pp. 267 - 274
Skin disorders are the most common adverse reactions attributed to drugs. Any skin disorder can be imitated, induced or aggravated by drugs. To help you keep... 
Skin disorders, drug-induced | Adverse drug reactions | Pharmacotherapy | Medicine & Public Health | Pharmacology/Toxicology | Dermatology | Dapsone - adverse effects | Cysteine - analogs & derivatives | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Ioxaglic Acid - adverse effects | Trichloroethylene - adverse effects | Glucans - adverse effects | Enoxaparin - adverse effects | Cefotetan - adverse effects | Minocycline - adverse effects | Anti-Inflammatory Agents - adverse effects | Anticonvulsants - adverse effects | Contrast Media - adverse effects | Triamcinolone - adverse effects | Taxoids | Antirheumatic Agents - adverse effects | Female | Anti-Bacterial Agents - adverse effects | Antineoplastic Agents, Phytogenic - adverse effects | Drug Eruptions - etiology | Glucose - adverse effects | Fructose - adverse effects | Adverse Drug Reaction Reporting Systems | Paclitaxel - analogs & derivatives | Paclitaxel - adverse effects | Solvents - adverse effects | Amlodipine - adverse effects | Anticoagulants - adverse effects | Cephamycins - adverse effects | Antihypertensive Agents - adverse effects | Dipyrone - adverse effects | Pregnancy | Diltiazem - adverse effects | Fructose - analogs & derivatives | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | BCG Vaccine - adverse effects | Adolescent | Cysteine - adverse effects | Aged | Gold Sodium Thiomalate - adverse effects | Ibuprofen - adverse effects | Echinacea - adverse effects
Journal Article
Transplant Infectious Disease, ISSN 1398-2273, 12/2018, Volume 20, Issue 6, pp. e12968 - n/a
Dapsone may be used for Pneumocystis jirovecii pneumonia (PJP) prophylaxis in hematology patients receiving immunosuppressive therapy or after hematopoietic... 
hematopoietic stem cell transplantation | adverse drug reactions | dapsone | Pneumocystis jirovecii pneumonia | CARINII-PNEUMONIA | INFECTIOUS DISEASES | GUIDELINES | IMMUNOLOGY | TRIMETHOPRIM-SULFAMETHOXAZOLE | TRANSPLANTATION | Dapsone - adverse effects | Hematologic Neoplasms - therapy | Hemolysis - drug effects | Anti-Infective Agents - adverse effects | Immunosuppression - methods | Humans | Middle Aged | Anti-Infective Agents - therapeutic use | Antibiotic Prophylaxis - methods | Pneumonia, Pneumocystis - immunology | Pneumonia, Pneumocystis - prevention & control | Male | Trimethoprim, Sulfamethoxazole Drug Combination - adverse effects | Anemia, Hemolytic | Antibiotic Prophylaxis - adverse effects | Dapsone - therapeutic use | Immunosuppression - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Female | Aged | Retrospective Studies | Oxidative Stress - drug effects | Pneumonia, Pneumocystis - microbiology | Pneumocystis carinii - isolation & purification | Medical research | Allergy | Pneumonia | Safety and security measures | Bacterial pneumonia | Dapsone | Transplantation | Allergic reaction | Hematopoietic stem cells | Sulfonamides | Immunotherapy | Stem cells | Medicine, Experimental | Drug therapy | Therapy | Toxicity | Hypersensitivity (delayed) | Exanthema | Prophylaxis | Trimethoprim | Stem cell transplantation | Malignancy | Immunosuppressive agents | Sulfamethoxazole | Human immunodeficiency virus--HIV | Myelosuppression | Hemolysis | Desensitization | Hematology | Risk perception | Diaminodiphenylsulfone | Patients | Reintroduction | Hemopoiesis | Reactivity | Index Medicus
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 05/2010, Volume 54, Issue 5, pp. 1762 - 1768
Journal Article
Journal of Dermatological Treatment, ISSN 0954-6634, 12/2013, Volume 24, Issue 6, pp. 408 - 410
Journal Article
American Journal of Clinical Dermatology, ISSN 1175-0561, 08/2015, Volume 16, Issue 4, pp. 231 - 242
Acne vulgaris is a very common chronic inflammatory disease of the skin. The clinical features of acne range from non-inflammatory comedones to inflammatory... 
PSEUDOMEMBRANOUS COLITIS | SALICYLIC-ACID | THERAPEUTIC-EFFICACY | DOUBLE-BLIND | CLINDAMYCIN 1-PERCENT | MINOCYCLINE-INDUCED PIGMENTATION | BENZOYL PEROXIDE | ADAPALENE GEL 0.1-PERCENT | DAPSONE GEL | PHARMACOLOGICAL-PROPERTIES | DERMATOLOGY
Journal Article
Journal of Investigative Dermatology, ISSN 0022-202X, 07/2018, Volume 138, Issue 7, pp. 1546 - 1554
Journal Article
The Journal of Allergy and Clinical Immunology, ISSN 0091-6749, 07/2019, Volume 144, Issue 1, pp. 44 - 45
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9700, pp. 1521 - 1532
Journal Article
Journal Article
Journal Article